CompletedNot applicableNCT02414672
Official study title

CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients

Study summary

The CareSTEPS intervention fills an important service gap by providing education, skills training, and support to the caregivers of advanced lung cancer patients on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the skills they need to provide care and meet the challenges of lung cancer, this intervention holds great promise for improving caregiver quality of life (QOL), patient QOL, and the quality of palliative and supportive care services offered to patients with advanced cancer and their families.

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedCareSTEPS

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 22, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Baylor College of Medicine

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Baylor College of Medicine
Interventions being studied
Behavioral: CareSTEPS
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patient has stage 3B or 4 NSLC or extensive stage SCLC and is within one month of treatment initiation
  • Patient is spending more than 50% of time out of bed on a daily basis, as measured by an ECOG Performance Status rating of level 0, 1, or 2
  • Patient has a spouse/partner other or close family member who he/she defines as the primary caregiver
  • Patient and caregiver \> 18 years
  • Patient/caregiver has the ability to read and understand English at a sixth grade level, as determined by his/her ability to understand the consent form
  • Patient/caregiver can provide informed consent
Reasons someone may not be able to joinExclusion criteria
  • Individuals with diminished mental capacity
  • Prisoners
  • Children
  • Pregnant Women
  • Fetuses

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Baylor College of MedicineHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 22, 2024. Always confirm current availability with the study team.

View original record ↗